Company Report
Last edited 3 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#217
Performance (51m)
-15.4% pa
Followed by
156
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcement 13/1/22
stale
Added 3 years ago

Graphene integrated with silicon electronics


Highlights

  • Archer addresses a key nanotech challenge in its biochip development by successfully integrating single atom-thick graphene on a silicon wafer
  • . Archer intends to use graphene as an ultrasensitive sensor for detecting and analysing diseases.
  • The biochip has been developed in-house by Archer staff and Archer owns 100% of the biochip technology intellectual property.  


https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02475306-2A1351139?access_token=83ff96335c2d45a094df02a206a39ff4

Disc: I hold

#Fabrication Begins 8/4/21
stale
Last edited 4 years ago

Archer begins sub-10 nanometre biochip fabrication

Highlights

  •  Archer commences biosensor nanofabrication process to sub-10 nanometre size, the current best-in-class in the semiconductor industry†.
  •  The significant reduction of size in biosensor components allows for hundreds of millions of biosensing devices on a 1 cm2 biochip.
  •  Miniaturisation to the sub-10 nanometre regime is a key requirement for the operation and end-use of Archer’s biochip.
  •  Some of the most sophisticated lithography facilities and systems for prototyping semiconductor devices are being utilised by Archer staff in Sydney, Australia.

† https://www.chiefscientist.nsw.gov.au/independent-reports/australian-semiconductor-sector-study https://www.youtube.com/watch?v=MtYEmR9F8OM (Intel Unleashed: Engineering the Future)

Also did a Company Presentation 25/3/21

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02357286-2A1289106?access_token=83ff96335c2d45a094df02a206a39ff4

Disc: I hold

View Attachment

#ASX Announcement 22/3/21
stale
Added 4 years ago

Archer strengthens biochip nanofabrication capabilities

https://www.asx.com.au/asxpdf/20210322/pdf/44tw244wjmf31p.pdf

Highlights:-

  •  Key biosensor components of Archer’s lab-on-a-chip device miniaturised to nanosize chip formats, a requirement for successful biochip development.
  •  Archer team grows, introducing world-class expertise and capabilities spanning nanotechnology, advanced materials, and molecular biology.
  •  The Company is utilising over $150 million of sophisticated chip building facilities in Australia to manufacture its graphene-based biochip technology.
  •  Lab-on-a-chip devices form part of the multibillion dollar deep-tech economy, catalysed by the global need for point of care medical diagnostics and testing

DISC: I hold

#ASX Announcements 12/1/21~Stud
stale
Added 4 years ago

Australian Semiconductor Sector Study

Archer Materials Limited (ASX: AXE) is pleased to inform shareholders that the Office of the NSW Chief Scientist & Engineer has published a comprehensive independent report, titled Australian Semiconductor Sector Study: Capabilities, opportunities and challenges for NSW’s meaningful participation in the global semiconductor value chain. Archer contributed to the development of the Scoping Study, together with other semiconductor sector leaders.

The Company encourages shareholders and investors to read the Scoping Study as it examines the global semiconductor market size and current and future trends, analyses NSW and Australian performance and capabilities to date, offers recommendations on what is needed for the sector’s constituents in NSW to successfully accelerate their participation in the high-value high-tech semiconductor industry, and prospective global market opportunities where Australian companies may hold a leading position, for example in Quantum Computing.

The Scoping Study identifies the largest areas of opportunity for the scaleup of companies, such as Archer, in the global semiconductor industry. These areas include enhancing domestic capability in semiconductor design, fabrication and prototyping. In particular, as it relates to the commercial translation of advanced materials and quantum computing technology.

The Scoping Study presents a positive long-term outlook for the potential of increased participation by companies such as Archer in the global semiconductor sector. Archer’s current areas of strength and strategic significance across the semiconductor value chain is reported to include securing high-impact intellectual property in global markets and chip development.

I haven't read it all yet, but I think a few of you might find it interesting. It is 48 pages...copy & paste

https://www.chiefscientist.nsw.gov.au/__data/assets/pdf_file/0005/339647/Australian-Semiconductor-Sector-Study.pdf